Skip to main content
Back to LUC.edu
Department of Ophthalmology
Stritch School of Medicine
Request Info Visit Apply

Charles S. Bouchard, MD, MA

Professor and Chair of Ophthalmology

Education

  • B.A., Biology - Bowdoin College, Brunswick, ME
  • M.A., Physiology - Boston University School of Medicine, Boston, MA
  • M.D., Northwestern University Medical School, Chicago, IL
  • Transitional Internship - St. Joseph Hospital, Chicago, IL
  • Resident in Ophthalmology - George Washington University, Washington, DC
  • Additional Training:
    • Fellow in Corneal and External Disease - Center for Sight,
    • Georgetown University, Washington, DC

Research Interests

Research Focus: Cornea and Ocular Surface Disease

Publications/Research Listings

Summary of Research Interests

My area of research focus is the diagnosis, pathophysiology and management of severe ocular surface diseases. This includes dry eye disease (DED), ocular graft vs host disease (oGVHD), mucus membrane pemphigoid (MMP), Steven’s Johnson Syndrome (SJS) and obstructive sleep apnea (OSA), all of which can affect the cornea and ocular surface leading to vision loss.

For the diagnosis of the diseases, we are studying various parameters and biomarkers that impact the homeostasis of the ocular surface.  This includes the ocular surface microbiome, tear film lipid payer, meibomian gland structure and function. We are also examining the relationship between tear film biomarkers (matrix metalloproteinase levels), and changes in the corneal biomechanics (hysteresis), as it relates to OSA.

For the pathophysiology of these OSA related disease, we are studying the role of local and systemic inflammatory biomarkers including tear film and systemic MMP-9 and systemic CRP, Hg A1c, and EPO. For SJS, we have studied the 20-year trends in culprit drugs and the inflammatory biomarkers in the acute phase of the disease. Currently we are collaborating in a study examining the genetic predisposition for SJS.

For the treatment arm, we are studying the role and composition of autologous serum tears, timing and efficacy various ocular surface reconstruction techniques including amniotic membrane, oral (buccal) mucosal grafts, corneal limbal stem cell transplantation, and lamellar allogeneic corneal transplants. We are currently studying eyelid procedures to retard the progression of surface disease in oGVHD  patients. Finally, the Loyola Burn Unit and Ophthalmology department are participating in a multicenter trial comparing the efficacy of systemic cyclosporine and etanercept in the management of acute SJS.

Publications

2026

  • Ashraf M, Shoraka E, Shahabi S, Ghalibafan S, Ahmed A, Karami Rad M, Bouchard CS, Saeed HN. Hormonal Modulation of Keratoconus: A Systematic Review and Screening Strategy for at-risk Populations. Ophthalmology Science 2026; published online. https://doi.org/10.1016/j.xops.2026.101072

2025

  • Sooranahalli C, Rao VR, Zelman B, Shekhar M, Komurlu Keceli S, Bouchard C, Iqbal O. The Potential Roles of IL-1β, IL-6, and RIPK3 in the Pathogenesis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Diagnostics (Basel). 2025 Jan 26;15(3):290. doi: 10.3390/diagnostics15030290. PMID: 39941220; PMCID: PMC11816709.

2024

  •  Jatavallabhula K, de Bustros P, Starnes T, Bouchard, CS. Assessing Ocular Involvement in Four Cases of Suspected Pembrolizumab-induced Stevens-Johnson Syndrome. International Journal of Ophthalmology & Visual Science 2024, Vol. x, No. x, pp. x–x https://doi.org/10.11648/j.ijovs.2024.
  • El-Khateeb H, Shekar M, Iqbal O, Dharan A, Campbell E, Bu P, Mudaliar K, Speiser J, and Bouchard CS. "The potential roles of IL-6 and NKG2C in the pathogenesis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis”." Clinical Research and Clinical Reports. 2024;3(4).  https://doi.org/10.31579/2835-8325/071.
  • Ramini A, Zhang N, Lee M, Vadakkepattath I, Sawant OB, Bouchard CS. The Impact of Donor History of Sleep Apnea on Corneal Tissue Evaluation Parameters. Cornea. 2024;43(6):e18.
  • Shekhar M, Iqbal O, Dharan A, El-Khateeb H, Jatavallabhula K, Bu P, Bouchard CS. The Role of NLRP3 Inflammasome in the Pathogenesis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Medical Research Archives. 2024;12(1). https://doi.org/10.18103/mra.v12i1.4939.

2023

  • Brahmbhatt P, Khanna S, Griffin S, Bouchard CS. A Retrospective Analysis of Tear Film and Blink Parameters in Patients With Ocular Surface Disease. Eye Contact Lens. 2023 May 11. doi: 10.1097/ICL.0000000000000994. Epub ahead of print. PMID: 37167586.
  • Zilliox MJ, Bouchard CS. The Microbiome, Ocular Surface, and Corneal Disorders. Am J Pathol. 2023;193(11):1648-1661. https://doi.org/10.1016/j.ajpath.2023.05.004.
  • Ueta M, Inoue C, Nakata M, Sotozono C, Kim MK, Wakamatsu T, Jongkhajornpong P, Saeed H, Rauz S, Ma D, Yoon KC, Puansricharern V, Bouchard CS, Ahmad S, Seo KY, Joo CK, Gomes JA, Kinoshita JC, Teramukai S. Severe Ocular Complications of SJS/TEN and associations between pre-onset, acute and chronic factors: a report from the International Ophthalmology Collaborative Group. Frontier Medicine. 2023; 10. doi: 10.3389/fmed.2023.1189140.
  • Marks, Madeline E., Ramya Krishna Botta, Riichiro Abe, Thomas M. Beachkofsky, Isabelle Boothman, Bruce C. Carleton, Wen-Hung Chung et al. "Updates in SJS/TEN: collaboration, innovation, and community." Frontiers in medicine. 10 2023. (https://sjsten2021.vfairs.com/).
  • Charles Bouchard. Enhancing Treatment of Acute Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis with Cryopreserved Amniotic Membrane. Ophthalmology 360, August, 2023.

2022

  • Phillips EJ, Bouchard CS, Divito SJ. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis-Coordinating Research Priorities to Move the Field Forward. JAMA Dermatol. 2022 March 30. doi: 10.1001/jamadermatol.2022.0484. Epub ahead of print. PMID: 35353140.
  • Abtahi, M., Adams, W., Agarwal, A., Agranat, JS., Ajlan, RS., Akhlaq, A. ... Zhu, I.  “Noninfectious Keratitis”, in Ophthalmology, Yanoff M, Duker J, eds., Mosby-Year Book, Inc. St. Louis, MO, 2022.
  • Bouchard CS. Diagnosis and Management of Blepharitis. Review of Ophthalmology. 2022 September.

2021

  • Metcalfe D, Iqbal O, Chodosh J, Bouchard CS, Saeed H. Acute and Chronic Management of Ocular Disease in Stevens Johnson Syndrome/Toxic Epidermal Necrolysis. Frontiers in Medicine. 2021 July; 8:662897. doi: 10.3389/fmed.2021.662897.
  • Bouchard CS. A Burning Issue. The Ophthalmologist. 2021 June; 20-25.
  • Sadek, Michael; Iqbal, Omer; Siddiqui, Fakiha; Till, Sean; Dharan, Adarsh; Mazariegos, Mellisa; Campbell, Edward; Mudaliar, Kumaran ; Speiser, Jodi ; Bontekoe, Emily; Kouta, Ahmed ; Farooqui, Amber ; Daravath, Bharathi ; Qnebi, Dalia; Sadek, Ramy; Hoppensteadt, Debra; Fareed, Jawed; Bouchard, Charles. The Role of IL-13, IL-15 and granulysin in the pathogenesis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Clinical and Applied Thrombosis/Hemostasis. 2021 February; 27:1076029620950831. doi: 10.1177/1076029620950831. PMID: 33560872.
  • Goldstein J, Ben Hadj Tahar M, Iqbal O, Fareed J, Bouchard CS. Stevens Johnson Syndrome/Toxic Epidermal Necrolysis and It’s Interface with Coagulation Activation. International Journal of Ophthalmology & Eye Science. 2021; 9(4): 472-477.
  • de Bustros P, Baldea A, Sanford A, Joyce C, Adams W, Bouchard CS. Review of Culprit Drugs Associated with Patients Admitted to the Burn Unit with the Diagnosis of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Syndrome. Journal of the International Society for Burn Injuries. (In Press 8-18-21).
  • Zhang CY, Farooq AV, Harocopos GJ, Sollenberger EL, Hou JH, Bouchard CS, Shieh C, Tran UL, Lubniewski AJ, Huang AJ, Paley GL. Corneal perforation in ocular graft-versus-host disease. American Journal of Ophthalmology Case Reports. 2021 December; 24. https://doi.org/10.1016/j.ajoc.2021.101224.

2020

  • Liu H, Gambino Jr F, Algenio CS, Wu C, Gao YC, Bouchard CS, Qiao L, Bu P, Zhao SZ. Inflammation and Oxidative Stress Induced by Lipid Peroxidation Metabolite 4-Hydroxynonenal in Human Corneal Epithelial Cells. Graefe's Archive for Clinical and Experimental Ophthalmology. 2020 May; 258: 1717-1725. doi: 10.1007/s00417-020-04647-2. PMID: 32445015.
  • Saeed HN, Bouchard CS, Shieh C, Phillips E, Chodosh J. Highlights from the 2nd Biennial Stevens Johnson Syndrome Symposium 2019: SJS/TEN From Science to Translation. The Ocular Surface. 2020 July; 18(3): 483-486. doi: 10.1016/j.jtos.2019.11.012. PMCID: PMC7307450.
  • Chang WC, Abe R, Anderson P, Anderson W, Ardern-Jones MR, Meachkofsky TM, Bellon T, Biala AK, Bouchard CS, Cavalleri GL, Chapman N, Chodosh J, Choi HK, Cibotti RR, Divito SJ, Karen D, Dehaeck U, Etminan M, Forbes D, Fuchs E, Goldman JL, Holmes IV J, Hope EA, Hung SL, Hsieh CL, Lovieno A, Jagdeo J, Kim MK, Koelle DM, Lacouture ME, Le Pallec S, McCawley J, McCawley J, Micheletti RG, Mockenhaupt M, Niemeyer K, Norcross MA, Oboh D, Olteanu C, Pasieka HB, Peter J, Pimohamed M, Rieder M, Saeed HN, Shear NH, Shieh C, Straus S, Sukasem C, Sung C, Trubiano JA, Tsou SY, Ueta M,  Volpi S, Wan C, Wang HS, Wang ZQ, Weintraub J, Whale C, Wheatley LM, Whyte-Croasdaile S, Williams KB, Wright G, Yeung SN, Zhou L, Chung WH, Phillips EJ, Carleton BC. SJS/TEN 2019: From science to translation. Journal of Dermatological Science. 2020 April; 98(1): 2-12. doi: 10.1016/j.jdermsci.2020.02.003. PMCID: PMC7261636.
  • Ripa M, Jabbehdari S, Yazdanpanah G, Lukacs E, Karcher B, Iqbal O, Bouchard CS. The Role of Multisystem Disease in Composition of Autologous Serum Tears and ocular surface symptom improvement. The Ocular Surface. 2020 July; 18(3):499-504. doi: 10.1016/j.jtos.2020.02.011. PMID: 32126284.
  • Sink J, Blatt S, Yoo D, Henry M, Yang S, Vasaiwala R, Ghadiali L, Adams W, Bouchard CS. A Novel Telemedicine Technique for Evaluation of Ocular Exam Findings via Smartphone Images. Journal of Telemedicine and Telecare. 2020 June. doi: 10.1177/1357633X20926819.  PMID: 32506998.
  • Zilliox MJ, Gange WS, Kuffel G, Mores CR, Joyce C, De Bustros P, Bouchard CS. Assessing the Ocular Surface Microbiome in Severe Ocular Surface Diseases. The Ocular Surface. 2020 July. doi: 10.1016/j.jtos.2020.07.007. PMID: 32717380.

2019

  • Thompson JM, Truong AH, Stern HD, Djalilian A, Cortina MS, Tu EY, Johnson P, Verdier DD, Rafo L, Lubeck D, Spektor T, Jorgensen C, Rubenstein JB, Majmudar PA, Talati R, Basti S, Feder R, Sugar A, Mian SI, Balasubramanian N, Sandhu J, Gaynes BI, Bouchard CS. A Multicenter Study Evaluating the Risk Factors and Outcomes of Repeat Descemet Stripping Endothelial Keratoplasty. Cornea. 2019 February; 38(2): 177-182. doi: 10.1097/ICO.0000000000001817. PMID: 30615600.
  • Cortina MS, Karas FI, Bouchard CS, Aref AA, Djalilian A, Vajaranant TS. Staged Ocular Fornix Reconstruction for Glaucoma Drainage Device under Neoconjunctiva at the time of Boston type 1 Keratoprosthesis Implantation. The Ocular Surface. 2019 April; 17(2): 336-340. doi: 10.1016/j.jtos.2019.01.010. PMID: 30742989.
  • Gao Y, Li CH, Bu P, Zhang LJ, Bouchard CS. Infectious Interface Keratitis (IIK) Following Lamellar Keratoplasty: A Literature Review. The Ocular Surface. 2019 October; 17(4): 635-643. doi: 10.1016/j.jtos.2019.08.001. PMID: 31415815.

2018

  • Adam N, Iqbal O, De Alba F, Kuffel G, Zilliox MJ, Adams W, Siddiqui Z, Patel R, O'Malley P, Park P, Stefonowicz C, Bouchard CS. Genetic Polymorphisms Associated with Risk of Developing Age-Related Macular Degeneration in Patients with Chronic Aspirin Usage. Journal of Ophthalmology Eye Care. 2018 May; 1(1): 101.
  • Liu H, Gambino Jr F, Algenio CS, Bouchard CS, Qiao L, Bu P, Zhao SZ. Zidovudine Protects Hyperosmolarity-Stressed Human Corneal Epithelial Cells via Antioxidant Pathway. Biochemical and Biophysical Research Communications. 2018 May; 499(2): 177-181. doi: 10.1016/j.bbrc.2018.03.112. PMID: 29555477.
  • Till SD, Iqbal O, Dharan A, Campbell E, Bu P, Mudaliar K, Speiser J, Bouchard CS. The Roles of IL-33 and TGF-Β1 in the Pathogenesis of Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis: Potential Biomarkers for Disease Severity. Journal of Ophthalmology Eye Care. 2018 September; 1(1): 105.
  • White KD, Abe R, Ardern-Jones M, Beachkofsky T, Bouchard CS, Carleton B, Chodosh J, Cibotti R, Davis R, Denny JC, Dodiuk-Gad RP, Ergen EN, Goldman JL, Holmes IV JH, Hung SL, Lacouture ME, Lehloenya RJ, Mallal S, Manolio TA, Micheletti RG, Mitchell CM, Mockenhaupt M, Ostrov DA, Pavlos R, Pirmohamed M, Pope E, Redwood A, Rosenbach M, Rosenblum MD, Roujeau, JC, Saavedra AP, Saeed HN, Struewing JP, Sueki H, Sukasem C, Sung C, Trubiano JA, Weintraub J, Wheatley LM, Williams KB, Worley B, Chung WH, Shear NH, Phillips EJ. SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation. Journal of Allergy Clinical Immunology: In Practice. 2018 January; 6(1): 38-69. doi: 10.1016/j.jaip.2017.11.023. PMCID: PMC5857362.
  • Sward M, Kirk C, Stefonowicz C, Kumar S, Nasir N, Adams W, Bouchard CS. Lax Eyelid Syndrome (LES), Obstructive Sleep Apnea (OSA), and Ocular Surface Inflammation. The Ocular Surface. 2018 July; 16(3): 331-336. doi: 10.1016/j.jtos.2018.04.003. PMID: 29729418.
  • Gange WS, Kirchner ID, Thompson JA, Hill J, Ibrahim T, Leonetti JP, Anderson DE, Bouchard CS. Ophthalmic complications following acoustic neuroma resection. Operative 2018 January; 14(1): 58-65. doi: 10.1093/ons/opx071. PMID: 29253289.
  • Adams N, Iqbal O, de Alba F, Kuffel G, Zilliox M, Bouchard C et al. Genetic Polymorphisms Associated with Risk of Developing Age-Related Macular Degeneration in Patients with Chronic Aspirin Usage. Journal of Ophthalmology and Eye Care 2018 May; 1(1): 1-8.

2016

  • Kohanim S, Palioura S, Saeed HN, Akpek EK, Amescua G, Basu S, Blomquist PH, Bouchard CS, Dart JK, Gai XW, Gomes JAP, Gregory DG, Iyer G, Jacobs DS, Johnson AJ, Kinoshita S, Mantagos IS, Mehta JS, Perez VL, Pflugfelder SC, Sangwan VS, Sippel KC, Sotozono C, Srinivasan B, Tan DTH, Tandon R, Tseng SCG, Ueta M, Chodosh J. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-A comprehensive review and guide to therapy. I Systemic Disease. The Ocular Surface. 2016 January; 14(1):2-19. doi: 10.1016/j.jtos.2015.10.002. PMID: 26549248.
  • Kohanim S, Palioura S, Saeed HN, Akpek EK, Amescua G, Basu S, Blomquist PH, Bouchard CS, Dart JK, Gai XW, Gomes JAP, Gregory DG, Iyer G, Jacobs DS, Johnson AJ, Kinoshita S, Mantagos IS, Mehta JS, Perez VL, Pflugfelder SC, Sangwan VS, Sippel KC, Sotozono C, Srinivasan B, Tan DTH, Tandon R, Tseng SCG, Ueta M, Chodosh J. Acute and Chronic Ophthalmic Involvement in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis - A Comprehensive Review and Guide to Therapy. II. Ophthalmic Disease. The Ocular Surface. 2016 April. 14(2): 168-188. doi: 10.1016/j.jtos.2016.02.001. PMID: 26882981.
  • Sivaraman KR, Jivrajka RV, Soin K, Bouchard CS, Movahedan A, Shorter E, Jain S, Jacobs DS, Djalilian, AR. Superior Limbic Keratoconjunctivitis-like Inflammation in Patients with Chronic Graft-Versus-Host Disease. The Ocular 2016 July; 14(3): 393-400. doi: 10.1016/j.jtos.2016.04.003. PMCID: PMC5554073.

2015

  • Syed D, Iqbal O, Mosier M, Mitchell R, Hoppensteadt D, Bouchard CS, Fareed J, Gamelli R. Elevated endocan levels and its association with clinical severity in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. International Angiology. 2015; 34(5): 483-8. PMID: 25394955.
  • Iqbal O, Bramble W, Ottman A, O’Malley P, Gaynes J, De Alba F, Gaynes BI, Fareed J, Bouchard CS. Aspirin and its Metabolites Enhance the Expression of Vascular Endothelial Growth Factor in Retinal Pigment Epithelial Cell Cultures – Implications in the Pathophysiology of Age-Related Macular Degeneration. International Journal of Ophthalmology and Eye Science.2015 August. 3(7), 115-120. doi: dx.doi.org/10.19070/2332-290X-1500025.

2014

  • Vira S, Abugo U, Shih CY, Udell IJ, Sperling B, Hannush SB, Basti S, Bouchard CS. Descemet stripping endothelial keratoplasty for the treatment of combined Fuchs corneal endothelial dystrophy and Keratoconus. Cornea. 2014 January; 33(1);1-5. doi: 10.1097/ICO.0b013e3182a7389c. PMID: 24240488.
  • Bu P, Vin AP, Sethupathi P, Ambrecht LA, Zhai YG, Nikolic N, Qiao L, Bouchard CS. Effects of Activated Omental Cells on Rat Limbal Corneal Alkali Injury. Experimental Eye Research. 2014 April; 121:143-146. doi: 10.1016/j.exer.2014.02.014. PMID: 24582890.

2013

  • Iqbal O, Fisher G, Vira S, Syed D, Sadeghi N, Freeman D, Campbell E, Sugar J, Feder R, Fareed J, Bouchard CS. Increased expression of secreted frizzled-related protein-1 and microtubule-associated protein light chain 3 in keratoconus. Cornea. 2013 May; 32(5):702-707. doi: 10.1097/ICO.0b013e318282987a. PMID: 23449484.
  • Vira S, Shih CY, Ragusa N, Sheyman A, Feder R, Weisenthal R, Rosenwasser GOD, Hannush SB, Udell IR, Bouchard CS. Textural interface opacity after Descemet stripping automated endothelial keratoplasty (DSAEK): A report of 30 cases and possible etiology. Cornea. 2013 May; 32(5):54-9. doi: 10.1097/ICO.0b013e31826429d5. PMID: 23132442.

2012

  • Banerjee PP, Edward DP, Liang S, Bouchard CS, Bryar PJ, Ahuja R, Dray P, Bailey DP. Concurrent and face validity of a capsulorhexis simulation with respect to human patients. Student Health Technology Inform. 2012; 173: 35-41. doi:10.3233/978-1-61499-022-2-35. PMID: 22356953.
  • Hsu M, Jayarum A, Verner R, Lin A, Bouchard CS. Indications and Outcomes of Amniotic Membrane Transplantation in the Management of Acute Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Case–Control Study. Cornea. 2012 December; 31(12): 1394-1402. doi: 10.1097/ICO.0b013e31823d02a8. PMID: 23135531.
  • Saidel MA, Paik JY, Garcia C, Russo P, Cao DC, Bouchard CS. Prevalence of sleep apnea syndrome and high-risk characteristics among keratoconus patients. Cornea. 2012 June; 31(6): 600–603. doi: 10.1097/ICO.0b013e318243e446. PMID: 22495032.
Full Publication List

 

Presentations

  • Bouchard CS. Surgical management of complex anterior segment disease. Presented at: Guatemala Ophthalmology Program; 2024 Apr 18; Guatemala.
  • Bouchard CS. Surgical Management of Severe Ocular Surface Disease. Presented at: Qinhuangdao First Hospital; 2024 Sep 24; Qinhuangdao, China.
  • Bouchard CS. Obstructive Sleep Apnea as a Risk Factor for Eye Disease: Evidence and Proposed Pathophysiology. Presented at: Tianjin Medical University Eye Hospital 35th Annual Meeting; 2024 Sep 28; Tianjin, China.
  • Bouchard CS. Moderator, interactive discussion sessions on troubleshooting steps of cataract surgery. Presented at: Northwestern University Phacoemulsification Training Course; 2024 Oct 5; Chicago, IL, USA.
  • Bouchard CS. Obstructive Sleep Apnea and Keratoconus. Presented at: 2024 Biennial Cornea Symposium, University of Illinois Chicago; 2024 Oct 12; Chicago, IL, USA.
  • Bouchard CS. Ocular Surface Microbiome in Health and Disease. Presented at: The Cornea Sub-Specialty Session, JCAHPO Annual Meeting; 2024 Oct 20; Chicago, IL, USA.
  • Bouchard CS. Tips and Tricks in Corneal Perforations and Descemetoceles: Present 2 cases of Peripheral Ulcerative Keratitis. Presented at: AAO Course; 2024 Oct 21; Chicago, IL, USA.
  • Bouchard CS. Management of Acute Stevens Johnson Syndrome in the US. Presented at: International Mini-Symposium, 78th Annual Congress of Japan Clinical Ophthalmology; 2024 Nov 14; Kyoto, Japan.
  • Bouchard C. Acute ocular manifestations of SJS. Presented at: Stevens Johnson Syndrome: from Science to Therapy; 2023 Sep 20; London, UK.
  • Bouchard C. Humanity First and Nasir Hospital, part of "Partnerships: How to Support Bidirectionality". Presented at: Global Ophthalmology Summit; 2023 Sep 8; Atlanta, GA, USA.
  • Bouchard C. Indications, Outcomes, and Mistakes to Avoid in Transitioning to Implantable Collamer Lenses (ICLs). Presented at: 2023 Northwestern University Annual Cataract Symposium; 2023 Jun 3; Chicago, IL, USA.
  • Bouchard C. Instrument Design and Handling For Proper Tissue Control. Presented at: Northwestern University Annual Phacoemulsification Course; 2023 Aug; Chicago, IL, USA.
  • Bouchard C. Invited speaker. Presented at: Real World Ophthalmology Program; 2023 Sep 30
  • Bouchard C. Microbiome in ocular surface disease. Presented at: The Cornea Sub-Specialty Session, JCAHPO Annual Meeting; 2023 Nov 4; San Francisco, CA, USA.
  • Bouchard C. Moderator for the "Loyola SJS Support Group Annual Conference". Presented at: Loyola SJS Support Group Annual Conference; 2023 Aug
  • Bouchard C. Ocular Surface Disease: Benefits of New Diagnostic Imaging Techniques. Presented at: JCAHPO Annual Meeting; 2023 Nov 5; San Francisco, CA, USA.
  • Bouchard C. Real World Ophthalmology, Session Moderator, "Tell Me Your Secrets: How Can I Become the Best Cataract and Refractive Surgeon." Presented at: Real World Ophthalmology; 2023 Apr 15; Denver, CO, USA.
  • Bouchard C, Kaffenberger B, Shupp J. Pro-Con: What is the best treatment for SJS/TEN. Co-Moderator. Presented at: SJSTEN 2023: Bringing Science to All annual meeting; 2023 Aug 27; Nashville, TN, USA.
  • Bouchard CS. The Ocular Surface Microbiome in Health and Disease. Presented at: Joint Commission on Allied Healthcare Personnel in Ophthalmology (JCAHPO) Course; 2022-2023.
  • Bouchard CS. The Ocular Surface Microbiome in Health and Disease. Presented at: SJS/TEN Loyola Support Group Symposium; August 11, 2022.
  • Bouchard CS. Immunogenic Disease of the Conjunctiva, Sclera and Cornea. Presented at: Northwestern Virtual Cornea Course; August 20, 2022; Chicago, IL.
  • Bouchard CS. The Ocular Surface Microbiome in Health and Disease. Presented at: JCAHPO's 50th Annual Continuing Education Program, Cornea, Refractive and Cataract Sub-Specialty Session; October 2, 2022; Chicago, IL.
  • Bouchard CS. Artificial Intelligence in Ophthalmology. Presented at: Humanity First Healthcare, Nasir Hospital; November 20, 2022; Guatemala.
  • Bouchard CS. Global Ophthalmology/Public Health Rotations. Presented at: Association of University Professors in Ophthalmology (AUPO) Break out Session; January 30, 2021; Virtual, Austin, TX.
  • Bouchard CS. Surgical Management of Severe Ocular Surface Disease. Presented at: Joint Commission on Allied Health Personnel in Ophthalmology (JCAHPO); June 15, 2021.
  • Bouchard CS. Clinical Findings and Medical Management of Severe Ocular Surface Disease. Presented at: American Society of Cataract and Refractive Surgery (ASCRS) Cornea Day; July 23, 2021; Las Vegas, NV.
  • Bouchard CS. Moderator: SJS/TEN 8th Annual Loyola Support Group Symposium. August 3, 2021.
  • Bouchard CS. Co-Chair, SJS/TEN 2021: Collaboration, Innovation & Community; Working Group: Theme 3: SJS/TEN Eye Care. Presented at: SJS/TEN 2021 Virtual Program; August 28-29, 2021.
  • Bouchard CS. Ocular Surface Disease: Benefits of New Diagnostic Imaging Techniques. Presented at: Joint Commission on Allied Health Personnel in Ophthalmology (JCAHPO) Annual Meeting; November 12, 2021; New Orleans, LA.
  • Bouchard CS. Surgical Management of Peripheral Ulcerative Keratitis. Presented at: American Academy of Ophthalmology Annual Meeting; November 2021; New Orleans, LA
  • Bouchard CS. The Future of Surgical Training in Ophthalmology: Simulation, Virtual Reality and Beyond. Presented at: Chicago Curriculum in Ophthalmology, Visionaries and Adversaries: 2020 and Beyond; January 18, 2020; Chicago, IL
  • Bouchard CS. Trends in Culprit Drugs Associated with Stevens Johnson Syndrome. Presented at: 5th International SJS Symposium; February 8, 2020; Kyoto, Japan.
  • Bouchard CS. Acute and Chronic Ocular Changes in Stevens Johnson Syndrome. Presented at: SJS Support Group Meeting; August 5, 2020; Vanderbilt University.
  • Bouchard CS. Ocular Manifestations of Sleep Apnea. Presented at: Australian Sleep Association, Australian Sleep Week Conference; October 23, 2020; Melbourne, Australia.
  • Bouchard CS. Anterior Segment Instrument Design and Proper Use for Maximum Control and Better Outcomes. Presented at: Northwestern University Annual Phacoemulsification Course; October 2020.
  • Bouchard CS. Surgical Management of Severe Ocular Surface Disease. Presented at: Joint Commission on Allied Health Personnel in Ophthalmology (JCAHPO); November 2020.
  • Bouchard CS. Obstructive Sleep Apnea, Lax Eyelids, and Ocular Disease; Dysfunctional Tear Syndrome (DTS): Strategies for Diagnosis and Management. Presented at: Spectrum Eye Institute; March 3, 2019; Ruffled Feathers Golf Club, Joliet, IL.
  • Bouchard CS. Meibography and Lipid Layer Analysis in the Diagnosis and Management of Dry Eye Disease. Presented at: ISEPS-COS Joint Conference Program; March 8, 2019; Chicago, IL.
  • Bouchard CS. Pathophysiology and Ocular Manifestations of Obstructive Sleep Apnea. Presented at: Department of Pathology, Loyola University Medical Center; March 28, 2019.
  • Bouchard CS. Discussant: Ocular Science and Eye Management. Presented at: SJS/TEN 2019: From Science to Translation; April 27, 2019; BC Children's Research Institute, Vancouver, BC, Canada.
  • Bouchard CS. Ocular Manifestations of Sleep Apnea: Pathophysiology and Management. Presented at: Department of Pathology, Loyola University Medical Center; May 9, 2019.
  • Bouchard CS. Anterior Segment Instrument Design and Proper Use for Maximum Control and Better Outcomes. Presented at: Northwestern University Annual Phacoemulsification Course; August 10, 2019.
  • Bouchard CS. Meibography and Lipid Layer Analysis in the Diagnosis and Management of Dry Eye Disease. Presented at: 11th International Meeting of the Tianjin Medical University Eye Hospital (TMUEH), Ocular Surface Diseases and Uveitis Symposium; September 29, 2019; Tianjin, China.
  • Bouchard CS. Panelist: Financial Arrangements between Academic Departments and VAMC Ophthalmology; Future Directions under Choice Act of 2017. Presented at: Annual Meeting of the Association of University Professors in Ophthalmology (AUPO); January 2018; Austin, TX.
  • Bouchard CS. The Ocular Surface Microbiome in Chronic Stevens Johnson Syndrome. Presented at: 3rd International SJS Symposium; February 3, 2018; Kyoto, Japan.
  • Bouchard CS. The Microbiome in the Normal and Diseased Ocular Surface. Presented at: ISEPS-COS Joint Conference Program; March 23, 2018; Chicago, IL.
  • Bouchard CS. Challenging Anterior Segment Surgery. Presented at: Guatemalan Ophthalmological Society; October 10, 2018; Guatemala City, Guatemala.
  • Bouchard CS. Noninfectious Keratitis. Presented at: Chicago Curriculum in Ophthalmology; November 3, 2018; Chicago, IL.
  • Bouchard CS. Update on the Medical and Surgical Management of Chronic SJS/TENS. Presented at: 2nd International SJS Symposium; January 21-22, 2017; Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Bouchard C. Management of Severe Ocular Surface Disease. Presented at: ISEPS-COS Joint Conference Program; 2016 Mar 11; Chicago, IL.
  • Bouchard C. Instrument Handling in Ophthalmology. Presented at: Northwestern University Annual Phacoemulsification Course; 2016 Sep 10.
  • Bouchard C. Ocular Manifestations of Sleep Apnea. Presented at: JCAHPO Annual Meeting; 2016 Oct 16; Chicago, IL.
  • Bouchard C. Indications and Outcomes of Repeat DSEK: A Multicenter Study. Presented at: Loyola China Symposium; 2016 Oct 19; Maywood, IL.
  • Bouchard C. Intersecting Aspects in Systemic and Ocular GVHD. Panelist at: University of Illinois Eye Center; 2016 Oct 22; Chicago, IL.